ELEVATION ONCOLOGY INC's ticker is ELEV and the CUSIP is 28623U101. A total of 32 filers reported holding ELEVATION ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $59,000 | – | 23,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 2,834,910 | $22,084,000 | 4.40% |
| venBio Partners LLC | 2,608,167 | $20,318,000 | 2.02% |
| Samsara BioCapital, LLC | 932,240 | $7,262,000 | 1.14% |
| Cormorant Asset Management, LP | 1,983,165 | $15,140,000 | 0.62% |
| BVF INC/IL | 1,590,298 | $12,388,000 | 0.48% |
| Boxer Capital, LLC | 1,341,530 | $10,451,000 | 0.36% |
| CAXTON CORP | 48,183 | $375,000 | 0.30% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,997,564 | $15,561,000 | 0.18% |
| Vivo Capital, LLC | 496,843 | $3,870,000 | 0.17% |
| CAAS CAPITAL MANAGEMENT LP | 60,000 | $467,000 | 0.01% |